For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Exelixis Inc (NASDAQ: EXEL) closed the day trading at $26.59 up 0.91% from the previous closing price of $26.35. In other words, the price has increased by $0.91 from its previous closing price. On the day, 2.36 million shares were traded. EXEL stock price reached its highest trading level at $27.015 during the session, while it also had its lowest trading level at $26.36.
Ratios:
For a better understanding of EXEL, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 7.57 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 27.33. For the most recent quarter (mrq), Quick Ratio is recorded 4.21 and its Current Ratio is at 4.27. In the meantime, Its Debt-to-Equity ratio is 0.09 whereas as Long-Term Debt/Eq ratio is at 0.09.
On December 19, 2023, BTIG Research started tracking the stock assigning a Buy rating and target price of $27.
On December 15, 2023, Citigroup started tracking the stock assigning a Buy rating and target price of $31.Citigroup initiated its Buy rating on December 15, 2023, with a $31 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 14 ’24 when Freire Maria C sold 8,250 shares for $26.56 per share. The transaction valued at 219,120 led to the insider holds 91,007 shares of the business.
Aftab Dana sold 20,883 shares of EXEL for $565,094 on Aug 12 ’24. The CSO/EVP Disc & Trans Research now owns 500,107 shares after completing the transaction at $27.06 per share. On Aug 14 ’24, another insider, MARIA C FREIRE, who serves as the Director of the company, bought 8,250 shares for $26.56 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EXEL now has a Market Capitalization of 7584850944 and an Enterprise Value of 6780861440. As of this moment, Exelixis’s Price-to-Earnings (P/E) ratio for their current fiscal year is 22.77, and their Forward P/E ratio for the next fiscal year is 18.12. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.07. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.77 while its Price-to-Book (P/B) ratio in mrq is 3.58. Its current Enterprise Value per Revenue stands at 3.367 whereas that against EBITDA is 15.792.
Stock Price History:
Over the past 52 weeks, EXEL has reached a high of $27.53, while it has fallen to a 52-week low of $18.64. The 50-Day Moving Average of the stock is 14.80%, while the 200-Day Moving Average is calculated to be 18.60%.
Shares Statistics:
Over the past 3-months, EXEL traded about 1.79M shares per day on average, while over the past 10 days, EXEL traded about 2919840 shares per day. A total of 302.79M shares are outstanding, with a floating share count of 277.78M. Insiders hold about 2.62% of the company’s shares, while institutions hold 86.39% stake in the company. Shares short for EXEL as of 1722384000 were 10163394 with a Short Ratio of 5.68, compared to 1719532800 on 9187474. Therefore, it implies a Short% of Shares Outstanding of 10163394 and a Short% of Float of 4.8.
